Eduardo Polo

2.2k total citations
19 papers, 356 citations indexed

About

Eduardo Polo is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Eduardo Polo has authored 19 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Surgery. Recurrent topics in Eduardo Polo's work include Colorectal Cancer Treatments and Studies (4 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). Eduardo Polo is often cited by papers focused on Colorectal Cancer Treatments and Studies (4 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). Eduardo Polo collaborates with scholars based in Spain, United Kingdom and Italy. Eduardo Polo's co-authors include Ricardo Escudero Cid, Félix Zamora, P. Ocón, M. Luisa Ruiz‐González, David Rodríguez‐San‐Miguel, Carmen Montoro, Jorge A. R. Navarro, P. Escudero, Dolores Isla and A. Trés and has published in prestigious journals such as Journal of the American Chemical Society, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Eduardo Polo

16 papers receiving 347 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eduardo Polo Spain 7 201 172 105 67 48 19 356
Chuanfang Liu China 14 187 0.9× 114 0.7× 122 1.2× 42 0.6× 30 0.6× 29 537
Zhengjun Guo China 7 124 0.6× 73 0.4× 37 0.4× 86 1.3× 45 0.9× 16 366
Jiajun Yu China 9 153 0.8× 35 0.2× 79 0.8× 41 0.6× 75 1.6× 22 484
Hye Ryeon Kim South Korea 8 232 1.2× 31 0.2× 108 1.0× 56 0.8× 24 0.5× 19 449
Hyemin Jeong South Korea 11 75 0.4× 45 0.3× 69 0.7× 24 0.4× 17 0.4× 24 364
Siyu Liu China 10 74 0.4× 58 0.3× 37 0.4× 13 0.2× 33 0.7× 30 303
Minqi Chen China 10 120 0.6× 52 0.3× 185 1.8× 16 0.2× 95 2.0× 20 439
Qiuxia Peng China 11 171 0.9× 20 0.1× 75 0.7× 42 0.6× 140 2.9× 39 443
Hirohito Suzuki Japan 9 132 0.7× 122 0.7× 10 0.1× 46 0.7× 10 0.2× 23 434

Countries citing papers authored by Eduardo Polo

Since Specialization
Citations

This map shows the geographic impact of Eduardo Polo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eduardo Polo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eduardo Polo more than expected).

Fields of papers citing papers by Eduardo Polo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eduardo Polo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eduardo Polo. The network helps show where Eduardo Polo may publish in the future.

Co-authorship network of co-authors of Eduardo Polo

This figure shows the co-authorship network connecting the top 25 collaborators of Eduardo Polo. A scholar is included among the top collaborators of Eduardo Polo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eduardo Polo. Eduardo Polo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Martínez, María Carmen Riesco, Jaume Capdevila, Vicente Alonso, et al.. (2024). Nivolumab plus platinum-doublet chemotherapy in treatment-naive patients with advanced grade 3 Neuroendocrine Neoplasms of gastroenteropancreatic or unknown origin: The multicenter phase 2 NICE-NEC trial (GETNE-T1913). Nature Communications. 15(1). 6753–6753. 10 indexed citations
2.
Capdevila, Jaume, Ismael Macías, Ignacio Escobar, et al.. (2023). Atezolizumab plus tiragolumab in combination with chemoradiotherapy in localized squamous cell carcinoma of the anal canal: TIRANUS (GEMCAD-2103) trial.. Journal of Clinical Oncology. 41(16_suppl). TPS3624–TPS3624.
3.
André, Thierry, Alfredo Falcone, Yaroslav Shparyk, et al.. (2023). Overall survival results for trifluridine/tipiracil plus bevacizumab vs capecitabine plus bevacizumab: Results from the phase 3 SOLSTICE study.. Journal of Clinical Oncology. 41(16_suppl). 3512–3512. 3 indexed citations
4.
Elez, Élena, Cristina Grávalos, Pilar García‐Alfonso, et al.. (2021). Effect of aflibercept plus FOLFIRI and potential efficacy biomarkers in patients with metastatic colorectal cancer: the POLAF trial. British Journal of Cancer. 126(6). 874–880. 5 indexed citations
5.
Grávalos, Cristina, Alfredo Carrato, Mercedes Rodríguez-Garrote, et al.. (2018). A Randomized Phase II Study of Axitinib as Maintenance Therapy After First-line Treatment for Metastatic Colorectal Cancer. Clinical Colorectal Cancer. 17(2). e323–e329. 15 indexed citations
6.
Montoro, Carmen, David Rodríguez‐San‐Miguel, Eduardo Polo, et al.. (2017). Ionic Conductivity and Potential Application for Fuel Cell of a Modified Imine-Based Covalent Organic Framework. Journal of the American Chemical Society. 139(29). 10079–10086. 230 indexed citations
7.
García‐Alfonso, Pilar, Enrique Grande, Eduardo Polo, et al.. (2014). The role of antiangiogenic agents in the treatment of patients with advanced colorectal cancer according to K-RAS status. Angiogenesis. 17(4). 805–821. 21 indexed citations
8.
Jiménez, Santiago & Eduardo Polo. (2011). Tratamiento de los síndromes periódicos asociados a la criopirina (CAPS). Medicina Clínica. 136. 29–33. 1 indexed citations
9.
García, C. Bousoño, et al.. (2009). [The megacystis-microcolon-intestinal hypoperistalsis syndrome: apropos of a case with prolonged survival].. PubMed. 23(5). 513–5. 4 indexed citations
10.
García, C. Bousoño, et al.. (2008). Síndrome de megavejiga-microcolon-hipoperistalsis intestinal: a propósito de un caso de supervivencia prolongada. Nutrición Hospitalaria. 23(5). 513–515. 5 indexed citations
11.
Mayordomo, José, Eugenia Ortega, Eduardo Polo, et al.. (2005). Gemcitabine/Capecitabine in Patients with Metastatic Breast Cancer Pretreated with Anthracyclines and Taxanes. Clinical Breast Cancer. 6(2). 158–162. 22 indexed citations
12.
Andrés, Raquel, José Mayordomo, Pedro Zaballos, et al.. (2004). Prognostic Value of Serum S-100B in Malignant Melanoma. Tumori Journal. 90(6). 607–610. 19 indexed citations
13.
Güemes, Antonio, Ramón Sousa, Ana Navarro, et al.. (2004). Aspectos técnicos y resultados de la mastectomía profiláctica en pacientes con elevado riesgo de cáncer de mama. Cirugía Española. 75(3). 123–128.
14.
Saenz, Alberto Hernández, José Mayordomo, Pedro Zaballos, et al.. (2003). Case 4. Hypertrophic osteoarthropathy associated with pulmonary metastasis of uterine leiomyosarcoma.. Journal of Clinical Oncology. 21(18). 3540–1. 4 indexed citations
15.
Saenz, Alberto Hernández, José Mayordomo, Pedro Zaballos, et al.. (2003). Unusual Abdominal and Pelvic Tumors. Journal of Clinical Oncology. 21(18). 3540–3541. 4 indexed citations
16.
Concha, Andrés, et al.. (2000). VARICELLA INFECTION AS A CAUSE OF ACUTE PANCREATITIS IN AN IMMUNOCOMPETENT CHILD. The Pediatric Infectious Disease Journal. 19(12). 1218–1219. 9 indexed citations
17.
García, C. Bousoño, et al.. (1996). [Nutritional status assessment in a group of cystic fibrosis patients].. PubMed. 44(1). 40–4. 2 indexed citations
18.
Polo, Eduardo, et al.. (1991). La responsabilidad civil, fiscal y penal de los administradores de las sociedades. Dialnet (Universidad de la Rioja). 1 indexed citations
19.
Polo, Eduardo, et al.. (1982). Síndrome de Aicardi: A propósito de dos observaciones. Anales de Pediatría. 16(4). 352–357. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chuanfang Liu Breakdown of academic impact, for papers by Zhengjun Guo Breakdown of academic impact, for papers by Jiajun Yu Breakdown of academic impact, for papers by Hye Ryeon Kim Breakdown of academic impact, for papers by Hyemin Jeong Breakdown of academic impact, for papers by Siyu Liu Breakdown of academic impact, for papers by Minqi Chen Breakdown of academic impact, for papers by Qiuxia Peng Breakdown of academic impact, for papers by Hirohito Suzuki
Rankless by CCL
2026